- 9 ماه پیش
- 490
- 04:16
Impact 49: SGLT2 inhibitors in CKD: are they really effective in all patients?
Daily Cardiology
0
توضیحات
SGLT2 inhibitors in CKD: are they really effective in all patients?
Avatar
کاربر شنوتواولین نفر کامنت بزار
21st ACC 2025 Congress Coverage: DapaTavi Trial
- 464
- 9 ماه پیش
🫀21st ACC.25 Congress Coverage: SGLT2 Inhibitors Progressing to New Standard After TAVI, DapaTAVI Trial, by Dr. Tahamtan, Fellowship of Electrophysiology.🔸Stay tuned for more insights from the late-...
🫀21st ACC.25 Congress Coverage: SGLT2 Inhibitors ...
01:54
- 464
- 9 ماه پیش
01:54
20th ACC 2025 Congress Coverage: ALLEPRE Trial
- 430
- 9 ماه پیش
🫀20th ACC.25 Congress Coverage: Alliance for secondary prevention after an acute coronary syndrome, ALLEPRE Trial, by Dr. Nasrollahizadeh, General Practitioner.🔸Stay tuned for more insights from the...
🫀20th ACC.25 Congress Coverage: Alliance for seco...
02:13
- 430
- 9 ماه پیش
02:13
تمامی حقوق این وبسایت متعلق به شنوتو است